1. Aspirin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing the ERK/MAPK pathway
    Hua Gao et al, 2017, Clinical and Experimental Hypertension CrossRef
  2. Deacetylated Sialic Acid Sensitizes Lung and Colon Cancers to Novel Cucurbitacin-Inspired Estrone Epidermal Growth Factor Receptor (EGFR) Inhibitor Analogs
    Mathias T. Anim et al, 2023, Molecules CrossRef
  3. USP22 acts as an oncogene by regulating the stability of cyclooxygenase-2 in non-small cell lung cancer
    Haibo Xiao et al, 2015, Biochemical and Biophysical Research Communications CrossRef
  4. Knockout of ADAM10 enhances sorafenib antitumor activity of hepatocellular carcinoma in vitro and in vivo
    WEI ZHANG et al, 2014, Oncology Reports CrossRef
  5. Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway
    TAO LI et al, 2016, Oncology Reports CrossRef
  6. COX-2 expression positively correlates with PD-L1 expression in human melanoma cells
    Gerardo Botti et al, 2017, Journal of Translational Medicine CrossRef
  7. Synthetic lethal combinations of low-toxicity drugs for breast cancer identifiedin silicoby genetic screens in yeast
    Maximilian Marhold et al, 2018, Oncotarget CrossRef
  8. Sorafenib Alleviates Inflammatory Signaling of Tumor Microenvironment in Precancerous Lung Injuries
    Betul Cicek et al, 2023, Pharmaceuticals CrossRef
  9. FTY720 (Fingolimod) sensitizes hepatocellular carcinoma cells to sorafenib‐mediated cytotoxicity
    Dilruba Ahmed et al, 2015, Pharmacology Research & Perspectives CrossRef
  10. Combination of celecoxib and calyculin-A inhibits epithelial-mesenchymal transition in human oral cancer cells
    Bharath Kumar Velmurugan et al, 2020, Biotechnic & Histochemistry CrossRef
  11. Design, synthesis, and biological evaluation of novel quinazolinyl-diaryl urea derivatives as potential anticancer agents
    Jia-Nian Chen et al, 2016, European Journal of Medicinal Chemistry CrossRef
  12. Aryl Hydrocarbon Receptor (AhR) Limits the Inflammatory Responses in Human Lung Adenocarcinoma A549 Cells via Interference with NF-κB Signaling
    Gerardo Vázquez-Gómez et al, 2022, Cells CrossRef
  13. Circ_001042 Inhibits TGF-β1/P38 MAPK Signaling Axis-Mediated Epithelial-Mesenchymal Transition and Metastasis in Lung Adenocarcinoma
    Lixia Zhou et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
  14. Design, syntheses and biological evaluation of natural product aiphanol derivatives and analogues: Discovery of potent anticancer agents
    Licheng Yao et al, 2023, Bioorganic & Medicinal Chemistry Letters CrossRef
  15. Upregulation of GRIM-19 suppresses the growth of oral squamous cell carcinoma in vitro and in vivo
    MINGHE LI et al, 2014, Oncology Reports CrossRef
  16. Design, synthesis, and biological evaluation of novel benzo[b]thiophene-diaryl urea derivatives as potential anticancer agents
    Omid Zarei et al, 2020, Medicinal Chemistry Research CrossRef
  17. Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells
    QU YANG et al, 2015, Oncology Reports CrossRef
  18. Enhanced antitumor effect of cisplatin in human oral squamous cell carcinoma cells by tumor suppressor GRIM-19
    MINGHE LI et al, 2015, Molecular Medicine Reports CrossRef
  19. Downregulation of matrix metalloproteinase 9 by small interfering RNA inhibits the tumor growth of ovarian epithelial carcinoma in vitro and in vivo
    FENGJUN GUO et al, 2015, Molecular Medicine Reports CrossRef
  20. Combined cetuximab and celecoxib treatment exhibits a synergistic anticancer effect on human oral squamous cell carcinoma in vitro and in vivo
    MING QIAN et al, 2014, Oncology Reports CrossRef
  21. Combined treatment of XIAP-targeting shRNA and celecoxib synergistically inhibits the tumor growth of non-small cell lung cancer cells in vitro and in vivo
    HONG ZHANG et al, 2015, Oncology Reports CrossRef
  22. Hypoxia promotes 786-O cells invasiveness and resistance to sorafenib via HIF-2α/COX-2
    Chun-Xiong Zhao et al, 2015, Medical Oncology CrossRef
  23. Cyclooxygenase-2 inhibitors in lung cancer treatment: Bench to bed
    Rui Liu et al, 2015, European Journal of Pharmacology CrossRef
  24. Pterostilbene enhances sorafenib’s anticancer effects on gastric adenocarcinoma
    Tingting Zhao et al, 2020, Journal of Cellular and Molecular Medicine CrossRef